Until recently, immunotherapy treatments have been traditionally offered through intravenous (IV) infusions. Recently, a new method for administering immunotherapy via subcutaneous injection (under the skin) has emerged to treat many types of cancer, offering the potential for less time spent on treatment and more comfort.
Receiving medicine through IV treatments can be challenging for both patients living with cancer and their caregivers. Preparation treatment can often be time-consuming, inconvenient, uncomfortable and add to the burden of disease. When it comes to immunotherapy, subcutaneous forms of treatment may offer comparable outcomes as IV, in a ready-to-use formula and with more flexibility to receive treatment closer to home.
Dr. Mecide Gharibo, vice president, U.S. Medical Hematology and Oncology, offers insights on subcutaneous immunotherapy as an option for patients and caregivers.